Navigation mit Access Keys

News

April 29, 2022

Virulence could be the Achilles heel of pathogens

The antibiotic resistance crisis is forcing us to rethink how to deal with bacterial pathogens. Prof. Médéric Diard’s team at the Biozentrum,…

April 19, 2022

Multiple treatments to slow age-related muscle wasting

Everyone wants to stay fit and healthy as they grow old. But as we age, our body degrades, our muscles shrink and strength declines. Some older people…

April 12, 2022

Blood vessel formation: how the vascular cells respond to blood pressure

Our blood vessels must remain sealed to prevent blood leakage. During blood vessel formation vascular cells are able to reinforce their cell junctions…

March 23, 2022

Genetic engineering in research: same same, but different

In order to better understand the recycling of receptors in the cell, Prof. Martin Spiess' team from the Biozentrum of the University of Basel…

March 17, 2022

Benjamin Engel awarded ERC Consolidator Grant

Benjamin Engel recently joined the Biozentrum of the University of Basel as an Assistant Professor of Structural Biology and Biophysics. For his…

March 03, 2022

Brain Prize 2022 for Silvia Arber

Prof. Silvia Arber from the Biozentrum, University of Basel, and at the Friedrich Miescher Institute for Biomedical Research receives the renowned…

March 02, 2022

Tackling the Achilles' heel of pneumonia-causing bacteria

Babies and infants are particularly at risk of developing severe pneumonia or meningitis caused by pneumococcus. The team of Prof. Camilo Perez at the…

February 28, 2022

Apply now! Biozentrum PhD Fellowships

With its prestigious and much sought after PhD Fellowships, the Biozentrum enables ambitious and highly motivated young scientists to do their PhD at…

February 28, 2022

Therapy for muscular dystrophy: A new start-up at the Biozentrum

Prof. Markus Rüegg and Dr. Judith Reinhard from the Biozentrum of the University of Basel have founded the start-up “SEAL Therapeutics AG” together…

February 18, 2022

Aukera Therapeutics qualifies for BaseLaunch funding program

The spin-off Aukera Therapeutics, which was founded at the Biozentrum last year, has been selected for the start-up accelerator program BaseLaunch.…